Home | Articles
Published on:September 2022
Indian Journal of Pharmaceutical Education and Research, 2022; 57(4s):xx-xx
Original Article | doi:

The Effect of Antioxidants and Cardiovascular Drugs in the Treatment of Cardiac Diseases


Authors and affiliation (s):

Swadesh Kumar Pattanik, Kishanta Kumar Pradhan*

Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi, Jharkhand, INDIA.

Abstract:

Background: Reactive oxygen species mediate oxidative stress, is one of the major causes of the athero-thrombotic process involved in the etiology of peripheral arterial disease, ischemic strokes, and heart attack. Angiotensin-1 receptor blockers, beta-blockers, angiotensin-converting enzyme inhibitors, diuretics, calcium channel blockers are traditional cardio-protective drugs. But the problem associated with these medications is, a person diagnosed with high blood pressure in younger age, has to take these drugs for lifelong, which may lead to develop harmful drug-induced diseases on long-term use like Alzheimer’s disease, Raynaud’s phenomenon, decreased levels of plasma catecholamines, etc. Materials: Among all anti-hypertensive agents, angiotensin-1 receptor blockers are safer as they have minimal long-term health hazards. Many pieces of the literature suggest that, intake of foods rich in anti-oxidant reduces the chance of cardiovascular disease, as they consume free radicals formed by various endogenous systems, pathological states or exposure to different physiochemical conditions, and improper oxidation of lipids. We can focus on synergistic benefit of both anti-hypertensive drug and antioxidants. Conclusion: Hence, we can assume that, intake of anti-oxidant as an active pharmaceutical ingredient may positively benefit in the treatment of cardiovascular diseases. Co-administration of existing cardiovascular drug and a suitable anti-oxidant(s) may produce a better result.

Keywords: Cardiovascular diseases, Oxidative stress, Reactive oxygen species, Antioxidants, AT1 receptor blocker.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs